المؤلفون: Berger M; Immunology Research and Development, CSL Behring, King of Prussia, PA 19406-0901, USA. mel.berger@cslbehring.com, Rojavin M, Kiessling P, Zenker O

المصدر: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2011 May; Vol. 139 (2), pp. 133-41. Date of Electronic Publication: 2011 Jan 23.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 100883537 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-7035 (Electronic) Linking ISSN: 15216616 NLM ISO Abbreviation: Clin Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Infusions, Subcutaneous* , Pharmacokinetics*, Immunoglobulin G/*administration & dosage , Immunoglobulin G/*therapeutic use , Immunologic Deficiency Syndromes/*therapy, Adolescent ; Adult ; Aged ; Area Under Curve ; Biological Availability ; Body Mass Index ; Brazil ; Child ; Europe ; Female ; Humans ; Immunoglobulin G/blood ; Immunoglobulins/administration & dosage ; Immunoglobulins/therapeutic use ; Immunoglobulins, Intravenous/administration & dosage ; Immunoglobulins, Intravenous/pharmacokinetics ; Immunoglobulins, Intravenous/therapeutic use ; Immunologic Factors/administration & dosage ; Immunologic Factors/pharmacokinetics ; Immunologic Factors/therapeutic use ; Male ; Middle Aged ; Therapeutic Equivalency ; United States ; United States Food and Drug Administration ; Young Adult

المؤلفون: Bonilla FA

المصدر: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2011 May; Vol. 139 (2), pp. 107-9. Date of Electronic Publication: 2011 Mar 03.

نوع المنشور: Comment; Editorial

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 100883537 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-7035 (Electronic) Linking ISSN: 15216616 NLM ISO Abbreviation: Clin Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Immunoglobulin G/*administration & dosage , Immunoglobulin G/*therapeutic use , Immunologic Deficiency Syndromes/*therapy, Area Under Curve ; Biological Availability ; Brazil ; Europe ; Humans ; Immunoglobulin G/blood ; Immunoglobulins/administration & dosage ; Immunoglobulins/therapeutic use ; Immunoglobulins, Intravenous/administration & dosage ; Immunoglobulins, Intravenous/pharmacokinetics ; Immunoglobulins, Intravenous/therapeutic use ; Immunologic Factors/administration & dosage ; Immunologic Factors/pharmacokinetics ; Immunologic Factors/therapeutic use ; Infusions, Subcutaneous ; Pharmacokinetics ; Therapeutic Equivalency ; United States ; United States Food and Drug Administration